World: Press Releases

Welcome to the Investing News Network's press release section, where you can stay informed with past and present announcements from our clients. Explore the latest stock news from mining, technology and life science companies and gain an investing edge by staying up to date with today's press releases.
Filters
Clear All Filters
Filter✕

Date Range

Sector

Seegnal (SEGN:CA)

Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

biotech-investing
Solvonis Therapeutics (None)

Expansion of SVN-015 into Depression Following Positive Preclinical Data

pharmaceutical-investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million

biotech-investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

biotech-investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

biotech-investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

biotech-investing
Invion Limited (IVX:AU)

Hanlim & Korean Government Fund Pathway to Clinical Trial

biotech-investing
Invion Limited (IVX:AU)

Invion Secures Expanded Photosoft Global Exclusive License

biotech-investing
Nextech3D.ai (NTAR:CC)

Nextech3D.ai Announces Definitive Agreement to Acquire 100% of ARway, Streamlining Operations

artificial-intelligence-investin
Cardiol Therapeutics (CRDL:CA)

New Data from the Phase II ARCHER Trial Demonstrate CardiolRx Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions

biotech-investing
Nextech3D.ai (NTAR:CC)

Nextech3D.ai Accelerates Eventdex Integration; Expands AI Matchmaking and Achieves Milestone Production of 800 Interactive Floor Plans in 2025

artificial-intelligence-investin
Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040

biotech-investing
Nextech3D.ai (NTAR:CC)

Nextech3D.ai Announces CEO Evan Gappelberg Acquires 550,000 Shares of Company Stock In Open Market Buys

artificial-intelligence-investin
Nextech3D.ai (NTAR:CC)

Nextech3D.ai Announces CEO Evan Gappelberg Acquires 550,000 Shares of Company Stock In Open Market Buys

artificial-intelligence-investin
Nextech3D.ai (NTAR:CC)

Nextech3D.ai Provides Update on Toggle3D.ai

artificial-intelligence-investin
Nextech3D.ai (NTAR:CC)

Nextech3D.ai and Arway Provide Business Combination Update

artificial-intelligence-investin
Nextech3D.ai (NTAR:CC)

Nextech3D.ai Provides Update on Toggle3D.ai

artificial-intelligence-investin
Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases

biotech-investing
Nextech3D.ai (NTAR:CNX)

Nextech3D.ai: Disrupting the Global Events Management Industry with AI and Blockchain

artificial-intelligence-investin
Invion Limited (IVX:AU)

Appendix 4C and Quarterly Activities Report - September 2025

biotech-investing

Latest press releases News

More press releases News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES